From: Racial differences in mantle cell lymphoma in the United States
 | Total (n = 5438) | Non-Hispanic white (n = 4458) | Hispanic white (n = 446) | Black (n = 241) | Asian/PI (n = 219) | P-value | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | Rate (95% CI) | n | Rate (95% CI) | n | Rate (95% CI) | n | Rate (95% CI) | n | Rate (95% CI) | ||
Age group | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
<40Â years | 75 | 78.0 (64.8-86.7) | 48 | 84.7 (69.6-92.7) | 12 | 66.8 (26.5-88.5) | 11 | 45.5 (7.8-78.4) | 3 | 100.0 | 0.7 |
40-64 years | 2257 | 61.9 (59.4-64.3) | 1802 | 63.1 (60.3-65.8) | 202 | 51.4 (42.3-59.7) | 126 | 58.0 (46.8-67.6) | 97 | 61.2 (48.8-71.4) | 0.523 |
65+ years | 3106 | 43.2 (40.7-45.7) | 2608 | 44.4 (41.7-47.1) | 232 | 35.5 (26.5-44.6) | 104 | 34.9 (22.5-47.5) | 119 | 41.2 (29.7-52.3) | 0.762 |
Gender | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Male | 3740 | 51.2 (49.0-53.3) | 3062 | 52.2 (49.8-54.5) | 330 | 43.6 (36.0-50.9) | 152 | 49.5 (39.0-59.2) | 148 | 46.6 (36.4-56.2) | 0.487 |
Female | 1698 | 53.1 (49.9-56.1) | 1396 | 54.9 (51.9-57.9) | 116 | 44.4 (32.6-55.5) | 89 | 45.4 (31.9-58.0) | 71 | 59.5 (44.2-71.9) | 0.259 |
Stage at diagnosis | Â | Â | Â | Â | Â | Â | Â | Â | Â | ||
Stage I | 633 | 72.6 (67.2-77.2) | 518 | 72.9 (66.9-78.0) | 46 | 64.2 (40.6-80.3) | 27 | 72.1 (41.6-88.5) | 33 | 73.7 (51.2-87.0) | 0.604 |
Stage II | 447 | 59.0 (52.7-64.8) | 365 | 59.7 (52.6-66.0) | 36 | 42.1 (18.7-64.0) | 17 | 46.0 (14.4-73.2) | 24 | 72.2 (45.3-87.5) | 0.983 |
Stage III | 780 | 45.6 (40.7-50.2) | 625 | 46.0 (40.6-51.2) | 70 | 39.1 (24.6-53.3) | 50 | 40.4 (23.2-57.0) | 28 | 62.0 (37.1-79.4) | 0.143 |
Stage IV | 3243 | 47.9 (45.6-50.1) | 2690 | 49.0 (46.5-51.5) | 263 | 39.8 (31.8-47.7) | 131 | 45.4 (34.2-55.9) | 125 | 37.6 (26.6-48.5) | 0.063 |